monoclonal antibody against PCSK9
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for monoclonal antibody against PCSK9, covering 2015-12-30 to 2015-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2 [Phase 3]